Pathfinder Properties PLC
5 December 2001
ANNOUNCEMENT
5 December 2001
Recommended revised offer ('the Offer' or 'the Revised Offer') by Pathfinder
Properties PLC ('Pathfinder Properties' or 'the Company') for Pathfinder
Recovery 1 PLC ('Recovery 1')
The Board of Pathfinder Properties announces that the Company has issued a
further 71,697 new Ordinary shares of 10p each in connection with the
acquisition of Recovery 1 Shares pursuant to the Offer. Application has been
made for these new shares to be admitted to trading on the Alternative
Investment Market of the London Stock Exchange and it is expected that
dealings in the new shares will commence on 11 December 2001.
The issued share capital of the Company following the issue of the new shares
is £7,962,185.30 divided into 79,621,853 Ordinary shares of 10p each.
The directors of Pathfinder Properties accept responsibility for the
information contained in this announcement. To the best of the knowledge and
belief of such directors (who have taken all reasonable care to ensure that
such is the case) the information contained in this announcement is in
accordance with the facts and does not omit anything likely to affect the
import of such information.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.